P.O. Box 208042, South Pavilion 2-213
New Haven, CT 06520-8042
Yale Interventional Radiology consists of a division of physicians specializing in the use of imaging modalities to guide the performance of minimally invasive diagnostic and therapeutic procedures in numerous parts of the body. Additionally, we are closely allied with Yale Vascular Surgery in a Yale Vascular Center, especially in the evaluation and treatment of arterial and venous blockages and aneurysms, including newer methods for angioplasty, the removal of material causing arterial blockage, and stent-grafts for aneurysms.
Other clinical interests include embolization for uterine fibroids, vascular anomalies, and pelvic congestion syndrome and varicoceles; minimally invasive treatment of cancer using embolization (including chemoembolization) and local treatments such as radiofrequency ablation; the management of varicose veins; interventions in bile ducts and the urinary track; and the placement of a variety of venous access devices.
Through the Yale Vascular Malformation Center, we are a world leader in the evaluation and treatment of patients with hereditary hemorrhagic telangiectasia (HHT, or Osler-Weber-Rendu syndrome).
Yale Interventional Radiologists see patients at our office in the Yale Physicians’ Building on Howard Avenue and perform procedures at Yale-New Haven Hospital and at the Veterans Administration Medical Center. In addition, we are active in training residents and fellows and conduct research.
Outcome of embolotherapy for pulmonary arteriovenous malformations
Transjugular intrahepatic portosystemic shunts
Locoregional therapy for hepatocellular carcinoma
Outcome after uterine fibroid embolization
Carotid artery stenosis
Thrombolytic spects and applications
CT angiography of peripheral vascular disease
Dynamic vascular imaging
Clinical applications of phase contrast imaging
Hemodialysis access catheters
Vascular imaging: improving vascular outcomes
Fenestrated endografts; branched endografts
Pelvic congestion syndrome and fibroid disease
Hereditary Hemorrhagic Telangiectasia
Yale Interventional Oncology Research Lab
Yale IR offers a unique research environment that encompasses the full gamut of basic, translational and clinical science, including clinical trials. Our NIH-funded science focuses on topics such as drug delivery, novel molecular targeted imaging and therapeutics, artificial intelligence and advanced intra-procedural navigation systems. We collaborate with partners in immunobiology, biomedical engineering and biophysics and have the most advanced experimental imaging equipment at our disposal, including a fully equipped state-of-the art Philips Allura Clarity C-Arm Interventional Suite. Our group has a track record of fostering careers of excellent IR trainees and junior faculty. Previous researchers and physician-scientists in IR won numerous national and international research prizes, such as the RSNA Trainee Prize, SIR Constantine Cope award, ECR Invest in Youth award and the prestigious PEO Foundation Award for Excellent Women in Science. Additional information can be found at the Yale Interventional Oncology Research Lab Website.
Yale IR residency training in the Yale New Haven Medical Center program is the only IR training program in the state of Connecticut. Yale IR residency received continued accreditation from the ACGME in 2019. We offer three IR Internship-Residency positions per year. We are accepting IR Intern-Residency applications through ERAS/NRMP on a yearly basis. For more information about the Yale IR residency program, click here.
Yale IR Global Outreach
Yale IR is a leader in global IR, bringing minimally invasive treatment options to underserved populations worldwide. In collaboration with Emory University and Muhimbili University of Health and Allied Sciences, Yale IR has established the first accredited IR training program in sub-Saharan Africa. Before initiation of this training program there was not a single interventional radiologist in Tanzania, an East African nation with a population of nearly 60 million people. This means that many essential and life-saving procedures could not be performed. Yale IR has coordinated deployment of 14 teams to Tanzania for two-week teaching trips since 2018, overseeing more than 300 IR procedures ranging from simple biopsies to complex vascular procedures. Yale IR recognizes the important role minimally invasive treatments will play in improving medical care in Africa and is committed to making these advances available to as many people as possible. This work is supported by several institutional and national grants, including the RSNA Research & Education Foundation Derek Harwood-Nash International Scholar Grant. For more information visit Yale IR Outreach Program Website and @road2IR on Twitter, Facebook, and Instagram.